| Combination therapy appears more effective than single drug for lower urinary tract symptoms | | Posted Wednesday, November 15, 2006 3:00:02 AM by Blog57 Team | | Men with overactive bladder and lower urinary tract symptoms who received a combination therapy were more likely to report improvement in symptoms than men who received only one medication, according to a study in the November 15 issue of JAMA, a theme issue on men's health. Steven A. Kaplan, M.D., of Weill Cornell Medical College, New York, presented the findings of the study today at a JAMA media briefing on men's health in New York. Overactive bladder is a syndrome characterized by urinary urgency, usually with increased urination frequency during the day and night. An estimated 10 million men 40 years or older have symptoms consistent with overactive bladder, according to background information in the article. Lower urinary tract symptoms include urinary hesitancy and intermittency and weak urinary stream.... | |
| |
| | | Tired of 'pressures,' doctors form large urology practice | | Posted Monday, September 04, 2006 11:06:45 AM by Blog57 Team | | To cope with the rising costs of running medical practices, three local groups of urologists have joined together, bringing 40 doctors under the banner of Chesapeake Urology Associates. The merger, effective Sept. 1, was borne out of the economic realities that many doctors say are putting pressures on their practices. Costs are rising, while payments from Medicare and private insurance companies are flat or declining. .... | |
| |
| | | DGAP-News: WaveLight AG Sells Urology Divison | | Posted Thursday, August 03, 2006 12:59:48 AM by Blog57 Team | | Corporate news transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- WaveLight: Concentration on Ophthalmology as Core Competence Med-tech Specialist Prepares Sales of Industrial Lasers Division Erlangen, July 31, 2006. The WaveLight Corporation, which is listed in the Deutsche Börse AG's Prime Standard, is moving forward with the implementation of its future-oriented reorganization strategy and has nearly completed the task of disincorporating its non-core divisions. The med-tech company announced today that it has sold its Urology Division. The sale was transacted in the context of a management buyout, with the participation of two prominent investors effectively securing both the financing of the MBO and the realization of the new company's future activities.... | |
| |
| | | Parameters associated with patient outcomes in lymph node positive prostate cancer | | Posted Wednesday, July 05, 2006 10:59:36 AM by Blog57 Team | | Dr. Hofer and colleagues report in the June issue of Urology that lymphovascular invasion (LVI) and the nuclear grade of the primary prostate tumor are independent predictors of PSA recurrence in men with lymph node positive CaP. The retrospective study included 119 eligible men with lymph node positive CaP who underwent radical prostatectomy at the University of Ulm Hospital, Germany. Clinical and pathologic examination was performed. The mean number of lymph nodes removed was 12 and the mean number positive was 3. Almost 50% of men had only 1 positive node, 22% had 2 and 34% had more than 2 positive nodes. PSA failure occurred n 41% of these men, leaving 59% free of disease with a mean follow-up of 41 months. The 5-year PSA failure-free survival rate was 61% and the mean PSA failure-free survival time was 54 months.... | |
| |
| |
|
|
